Author/Authors :
Tanyeli, Ömer Necmettin Erbakan Konya University - Meram Medicine Faculty - Department of Cardiovascular Surgery, Turkey , Dereli, Yüksel Necmettin Erbakan University - Meram Faculty of Medicine - Department of Cardiovascular Surgery, Turkey , Düzenli, Mehmet Akif Necmettin Erbakan University - Meram Faculty of Medicine - Department of Cardiovascular Surgery, Turkey , Görmüş, Niyazi Necmettin Erbakan University - Meram Faculty of Medicine - Department of Cardiology, Turkey
Abstract :
Reteplase, a recombinant plasminogen activator, is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent ST elevation or recent left bundle-branch block within 12 h; however, its use on stuck mechanical valves remains controversial.
